Medical needles and electrodes with improved bending stiffness

ABSTRACT

A device for penetrating tissue includes an elongated element having a distal end, a proximal end, a body extending between the distal and the proximal ends, and a lumen located within at least a portion of the body, wherein the lumen has a cross-sectional shape that is a polygon. A device for penetrating tissue includes an elongated element having a distal end, a proximal end, and a body extending between the distal and the proximal ends, at least a portion of the body having a cross-sectional profile that is a polygon, wherein the elongated element is a cannula.

RELATED APPLICATION DATA

This application is a continuation of pending U.S. patent applicationSer. No. 12/693,273, filed Jan. 25, 2010, which is a continuation ofU.S. patent application Ser. No. 11/078,933, filed on Mar. 10, 2005, nowU.S. Pat. No. 7,678,107, the entire disclosures of which are expresslyincorporated by reference herein.

FIELD OF THE INVENTION

The field of the invention relates generally to medical devices, andmore particularly, to tissue-penetrating elements, such as electrodesand needles, and medical devices having such tissue-penetratingelements.

BACKGROUND OF THE INVENTION

Many existing medical devices includes tissue-penetrating elements. Forexample, U.S. Pat. No. 5,855,576 describes an ablation apparatus thatincludes a plurality of electrode tines (elongated electrodes)deployable from a cannula. Each of the tines includes a proximal endthat is coupled to a generator, and a distal end that may project from adistal end of the cannula. When using the above described devices inpercutaneous interventions, the cannula is generally inserted through apatient's skin to penetrate tissue, and the elongated electrodes aredeployed out of the distal end of the cannula. The electrodes are thenenergized to ablate the target tissue.

It has been found that elongated electrodes have relatively low bendingstiffness, thereby allowing the electrodes to easily bend during use.Sometimes, the bending of the electrodes may result in a deployedconfiguration of the electrodes within tissue that is not as thatintended.

Also, sometimes it may be desirable to reposition the cannula and deploythe electrodes at a different location to create an additional lesion.For example, the cannula can be retracted and removed from the firsttarget site, and reinserted into a new target site. However, suchtechnique results in multiple puncture wounds and may increase thechance of metastasis resulted from cancer seeds migrating to otherbodily locations through the puncture wounds. Sometimes, in order tominimize puncture wounds, a physician may attempt to turn or steer thedistal end of the cannula (e.g., by applying a bending force at theproximal end of the cannula) to aim the distal end at different targettissue while the distal end is still inside the tissue. However, thecannula used to deploy the electrodes generally has relatively lowbending stiffness, thereby preventing a physician from applying bendingforce at the proximal end of the cannula (e.g., applying a torque aboutan axis that is at an angle relative to an axis of the cannula).

Tissue-penetrating elements, such as medical needles, have also beenused in a variety of applications. For examples, medical needles havebeen used to deliver substance, such as drug, contrast agent, diagnosticagent, and radioactive objects, to patients. Medical needles have alsobeen used to collect substance, such as blood, tissue, or other bodilyfluid, from a patient. In either case, the medical needle generally hasa sharp distal tip for penetrating tissue, and is attached to acontainer in which the substance to be delivered or collected is stored.During use, the needle tip is used to pierce through a patient's skin toreach target site, and the substance is delivered to, or collected from,the target site via the needle.

Sometimes, in order to minimize the size of the wound at the patient'sskin, the needle is made to have a circular cross-section having a smallcross-sectional diameter. However, a needle with such configuration canbend easily as it is advanced into a patient's body, thereby resultingin the needle tip being inaccurately positioned.

Thus, there remains a need to provide for improved tissue-penetratingelements, such as elongated electrodes and medical needles, with goodbending stiffness.

SUMMARY OF THE INVENTION

In accordance with some embodiments, a device for penetrating tissueincludes an elongated element having a distal end, a proximal end, abody extending between the distal and the proximal ends, and a lumenlocated within at least a portion of the body, wherein the lumen has across-sectional shape that is a polygon.

In accordance with other embodiments, a device for penetrating tissueincludes an elongated element having a distal end, a proximal end, and abody extending between the distal and the proximal ends, at least aportion of the body having a cross-sectional profile that is a polygon,wherein the elongated element is a cannula.

Other and further aspects and features of the invention will be evidentfrom reading the following detailed description of the preferredembodiments, which are intended to illustrate, not limit, the invention.

BRIEF DESCRIPTION OF THE DRAWINGS

The drawings illustrate the design and utility of preferred embodiments.It should be noted that the figures are not drawn to scale and thatelements of similar structures or functions are represented by likereference numerals throughout the figures. Understanding that thesedrawings depict only typical embodiments of and are not therefore to beconsidered limiting of its scope, the embodiments will be described andexplained with additional specificity and detail through the use of theaccompanying drawings in which:

FIG. 1 is a schematic diagram of a tissue ablation system in accordancewith some embodiments;

FIG. 2 is a perspective view of the ablation probe used in the system ofFIG. 1, wherein an electrode array is particularly shown retracted;

FIG. 3 is a perspective view of the ablation probe of FIG. 2, wherein anelectrode array is particularly shown deployed;

FIG. 4 illustrates a partial side cross-sectional view of the electrodeof FIG. 2;

FIG. 5 illustrates a cross-sectional view of the electrode of FIG. 4;

FIGS. 6-9 illustrate alternative cross-sections of the electrode of FIG.4;

FIGS. 10A-10C are cross-sectional views, showing a method for treatingtissue, in accordance with some embodiments;

FIG. 11 illustrates a partial side cross-sectional view of atissue-penetrating element having a lumen in accordance with someembodiments;

FIG. 12 illustrates a cross-sectional view of the tissue-penetratingelement of FIG. 11;

FIGS. 13-16 illustrate alternative cross-sections of thetissue-penetrating elements of FIG. 11; and

FIG. 17 illustrates a side cross-sectional view of a tissue-penetratingelement in accordance with other embodiments, showing thetissue-penetrating element having a side opening.

DETAILED DESCRIPTION OF THE EMBODIMENTS

FIG. 1 illustrates a tissue ablation system 2 constructed in accordancewith some embodiments of the invention. The tissue ablation system 2includes a probe assembly 4 configured for introduction into the body ofa patient for ablative treatment of target tissue, and a radio frequency(RF) generator 6 configured for supplying RF energy to the probeassembly 4 in a controlled manner.

Referring specifically now to FIGS. 2 and 3, the probe assembly 4includes an elongate cannula 12, a shaft 20 slidably disposed within thecannula 12, and an array 30 of electrodes 26 carried by the shaft 20.The array 30 of electrodes 26 can be manufactured as a single component.As such, the “array of electrodes” should not be limited to a pluralityof separate electrodes, and includes a single structure (e.g., anelectrode) having different conductive portions. The cannula 12 has adistal end 14, a proximal end 16, and a central lumen 18 extendingthrough the cannula 12 between the distal end 14 and the proximal end16. The cannula 12 may be rigid, semi-rigid, or flexible depending uponthe designed means for introducing the cannula 12 to the target tissue.The cannula 12 is composed of a suitable material, such as plastic,metal or the like, and has a suitable length, typically in the rangefrom 5 cm to 30 cm, preferably from 10 cm to 20 cm. The length of thecannula 12 can also have other dimensions. If composed of anelectrically conductive material, the cannula 12 is preferably coveredwith an insulative material. The cannula 12 has an outside crosssectional dimension consistent with its intended use, typically beingfrom 0.5 mm to 5 mm, usually from 1.3 mm to 4 mm. The cannula 12 mayhave an inner cross sectional dimension in the range from 0.3 mm to 4mm, preferably from 1 mm to 3.5 mm. The cannula 12 can also have otheroutside and inner cross sectional dimensions in other embodiments.

It can be appreciated that longitudinal translation of the shaft 20relative to the cannula 12 in a distal direction 40 deploys theelectrode tines 26 from the distal end 14 of the cannula 12 (FIG. 3),and longitudinal translation of the shaft 20 relative to the cannula 12in a proximal direction 42 retracts the electrode tines 26 into thedistal end 14 of the cannula 12 (FIG. 2). The shaft 20 comprises adistal end 22 and a proximal end 24. Like the cannula 12, the shaft 20is composed of a suitable material, such as plastic, metal or the like.

In the illustrated embodiment, each electrode 26 takes the form of anelectrode tine, which resembles the shape of a needle or wire. Each ofthe electrodes 26 is in the form of a slander metal element, which canpenetrate into tissue as it is advanced from a target site within thetarget region. In some embodiments, distal ends 102 of the electrodes 26may be honed or sharpened to facilitate their ability to penetratetissue. The distal ends 102 of these electrodes 26 may be hardened usingconventional heat treatment or other metallurgical processes. They maybe partially covered with insulation, although they will be at leastpartially free from insulation over their distal portions.

When deployed from the cannula 12, the array 30 of electrodes 26 has adeployed configuration that defines a volume having a periphery with aradius in the range from 0.5 to 4 cm. However, in other embodiments, theradius can be other values. The electrodes 26 are resilient andpre-shaped to assume a desired configuration when advanced into tissue.In the illustrated embodiments, the electrodes 26 diverge radiallyoutwardly from the cannula 12 in a uniform pattern, i.e., with thespacing between adjacent electrodes 26 diverging in a substantiallyuniform and/or symmetric pattern. The electrodes 26 should not belimited to having the profiles shown in FIG. 3, and that in alternativeembodiments, the electrodes 26 can have different deployed profiles.

It should be noted that although a total of two electrodes 26 areillustrated in FIG. 3, in other embodiments, the probe assembly 4 canhave more or fewer than two electrodes 26. In exemplary embodiments,pairs of adjacent electrodes 26 can be spaced from each other in similaror identical, repeated patterns and can be symmetrically positionedabout an axis of the shaft 20. It will be appreciated that a widevariety of particular patterns can be provided to uniformly cover theregion to be treated. In other embodiments, the electrodes 26 may bespaced from each other in a non-uniform pattern.

The electrodes 26 can be made from a variety of electrically conductiveelastic materials. Very desirable materials of construction, from amechanical point of view, are materials which maintain their shapedespite being subjected to high stress. Certain “super-elastic alloys”include nickel/titanium alloys, copper/zinc alloys, or nickel/aluminumalloys. Alloys that may be used are also described in U.S. Pat. Nos.3,174,851, 3,351,463, and 3,753,700, the disclosures of which are herebyexpressly incorporated by reference. The electrodes 26 may also be madefrom any of a wide variety of stainless steels. The electrodes 26 mayalso include the Platinum Group metals, especially platinum, rhodium,palladium, rhenium, as well as tungsten, gold, silver, tantalum, andalloys of these metals. These metals are largely biologically inert.They also have significant radiopacity to allow the electrodes 26 to bevisualized in-situ, and their alloys may be tailored to accomplish anappropriate blend of flexibility and stiffness. They may be coated ontothe electrodes 26 or be mixed with another material used forconstruction of the electrodes 26.

Referring to FIG. 4, which illustrates a partial cross-sectional sideview of the electrode 26 (tissue-penetrating element) constructed inaccordance with some embodiments of the invention. The electrode 26 hasa distal end 102, a proximal end 104, and a body 106 between the distaland the proximal ends 102, 104. The electrode 26 further includes asharp distal tip 108 for penetrating tissue. As used in thisspecification, the term “tissue-penetrating element” is not limited tostructures that have tissue piercing capability, and includes structuresthat do not have tissue piercing capability, as long as the structuresare placeable or adapted to be placed at least partially within a body.

FIG. 5 illustrates a cross-sectional view of the electrode 26 of FIG. 4.As shown in FIG. 5, at least a portion of the body 106 of the electrode26 has a square profile, with a plurality of sides 120. The body 106 issized such that the sides 120 are tangential to a circle (shown indotted lines) having a prescribed radius (or dimension) 128.Particularly, a distance 126 between a midpoint 122 on a side 120 and acenter 124 of the square is equal to the prescribed dimension 128. Inthe illustrated embodiments, the prescribed dimension 128 can be anyvalue between 0.01 cm to 0.5 cm, and more preferably, between 0.04 cm to0.3 cm. The prescribed dimension 128 can be other values in otherembodiments. The square cross-sectional profile/shape of the body 106 isadvantageous over a circular cross-sectional profile (having radiusequal to the prescribed dimension 128) in that, for a given prescribeddimension 128, the square cross-sectional profile provides bettercross-sectional property (e.g., higher moment of inertia I), therebyresulting in the body 106 having a stronger bending stiffness than thatof the circular cross-sectional profile.

In other embodiments, the body 106 can be sized such that the electrode26 has a prescribed bending stiffness. For example, the body 106 can besized to have a prescribed bending stiffness such that when theelectrode 26 is deployed within tissue, the electrode 26 willsubstantially assume its intended delivery shape. The bending stiffnessof the electrode 26 is a function of a moment of inertia (I) of thecross-section of the body 106. Generally, a cross-section of theelectrode 26 with a higher moment of inertia will provide a higherbending stiffness for the electrode 26. A square cross-sectional profilesized to have a prescribed moment of inertia will have a smallercross-sectional dimension (equal to two times the distance 126) thanthat of a circular cross-sectional profile sized to have the sameprescribed moment of inertia. As such, the square cross-sectionalprofile is better than a circular cross-sectional profile in that, for agiven material of construction, it can provide the prescribed bendingstiffness for the electrode 26, while allowing the electrode 26 to beconstructed with a smaller cross-sectional dimension.

It should be noted that in alternative embodiments, instead of a squareprofile, at least a portion of the electrode body 106 can have othercross-sectional profiles, such as a triangle (FIG. 6), a pentagon (FIG.7), a hexagon (FIG. 8), and an octagon (FIG. 9). As similarly discussedpreviously, any of the polygon cross-sectional profiles illustrated inFIGS. 6-9 is advantageous over a circular cross-sectional profile. Also,in other embodiments, instead of having the deployed profile shown inFIG. 3, the electrode 26 can have a straight deployed profile, otherdeployed curvilinear profiles (such as an arc, or a bent), or othercustomized deployed profiles.

Returning to FIGS. 2 and 3, the probe assembly 4 further includes anelectrode 92 secured to the cannula 12. The electrode 92 is operative inconjunction with the array 30 to deliver energy to tissue. Theelectrodes 26 in the array 30 are positive (or active) electrodes whilethe operative electrode 92 is a negative (or return) electrode forcompleting energy path(s). In such cases, energy is directed from theelectrodes 26 in the array 30 radially inward towards the electrode 92.Alternatively, the electrode 92 can be active electrode while theelectrodes 26 in the array 30 are return electrodes for completingenergy path(s), in which cases, energy is directed from the electrode 92radially outward towards the electrodes 26. In the illustratedembodiments, the operative electrode 92 has a tubular shape, but canhave other shapes in alternative embodiments.

In the illustrated embodiments, the array 30 of electrodes 26 and theoperative electrode 92 are used to deliver RF current in a bipolarfashion, which means that current will pass between the array 30 ofelectrodes 26 and the operative electrode 92. In a bipolar arrangement,the array 30 and the electrode 92 will be insulated from each other inany region(s) where they would or could be in contact with each otherduring a power delivery phase.

Alternatively, the RF current is delivered to the electrode array 30 ina monopolar fashion, which means that current will pass from theelectrode array 30, which is configured to concentrate the energy fluxin order to have an injurious effect on the surrounding tissue, and adispersive electrode (not shown), which is located remotely from theelectrode array 30 and has a sufficiently large area (typically 130 cm²for an adult), so that the current density is low and non-injurious tosurrounding tissue. In such cases, the electrode assembly 4 does notinclude the operative electrode 92. The dispersive electrode may beattached externally to the patient, e.g., using a contact pad placed onthe patient's flank.

The probe assembly 4 further includes a handle assembly 27, whichincludes a handle portion 28 mounted to the proximal end 24 of the shaft20, and a handle body 29 mounted to the proximal end 16 of the cannula12. The handle portion 28 is slidably engaged with the handle body 29(and the cannula 20). The handle portion 28 also includes an electricalconnector 38, which allows the probe assembly 2 to be connected to thegenerator 6 during use. The electrical connector 38 is electricallycoupled to the electrodes 26. The electrical connector 38 can beconveniently coupled to the electrodes 26 via the shaft 20 (which willbe electrically conductive), although in other embodiments, theconnector 38 can be coupled to the electrodes 26 via separate wires (notshown). The handle portion 28 and the handle body 29 can be composed ofany suitable rigid material, such as, e.g., metal, plastic, or the like.

Referring back to FIG. 1, the RF generator 6 is electrically connectedto the electrical connector 38, which may be directly or indirectly(e.g., via a conductor) electrically coupled to the electrode array 30.The RF generator 6 is a conventional RF power supply that operates at afrequency in the range from 200 KHz to 1.25 MHz, with a conventionalsinusoidal or non-sinusoidal wave form. Such power supplies areavailable from many commercial suppliers, such as Valleylab, Aspen, andBovie. Most general purpose electrosurgical power supplies, however,operate at higher voltages and powers than would normally be necessaryor suitable for vessel occlusion. Thus, such power supplies wouldusually be operated at the lower ends of their voltage and powercapabilities. More suitable power supplies will be capable of supplyingan ablation current at a relatively low voltage, typically below 150V(peak-to-peak), usually being from 50V to 100V. The power will usuallybe from 20 W to 200 W, usually having a sine wave form, although otherwave forms would also be acceptable. Power supplies capable of operatingwithin these ranges are available from commercial vendors, such asBoston Scientific Corporation of San Jose, Calif., which markets thesepower supplies under the trademarks RF2000 (100 W) and RF3000 (200 W).

Referring now to FIGS. 10A-10C, the operation of the tissue ablationsystem 2 is described in treating a treatment region TR within tissue Tlocated beneath the skin or an organ surface S of a patient. The cannula12 is first introduced within the treatment region TR, so that thedistal end 14 of the cannula 12 is located at the target site TS, asshown in FIG. 10A. This can be accomplished using any one of a varietyof techniques. In some cases, the cannula 12 and shaft 20 may beintroduced to the target site TS percutaneously directly through thepatient's skin or through an open surgical incision. In this case, thecannula 12 (or the electrode 92) may have a sharpened tip, e.g., in theform of a needle, to facilitate introduction to the target site TS. Insuch cases, it is desirable that the cannula 12 be sufficiently rigid,i.e., have a sufficient column strength, so that it can be accuratelyadvanced through tissue T. In other cases, the cannula 12 may beintroduced using an internal stylet that is subsequently exchanged forthe shaft 20 and electrode array 30. In this latter case, the cannula 12can be relatively flexible, since the initial column strength will beprovided by the stylet. More alternatively, a component or element maybe provided for introducing the cannula 12 to the target site TS. Forexample, a conventional sheath and sharpened obturator (stylet) assemblycan be used to initially access the tissue T. The assembly can bepositioned under ultrasonic or other conventional imaging, with theobturator/stylet then removed to leave an access lumen through thesheath. The cannula 12 and shaft 20 can then be introduced through thesheath lumen, so that the distal end 14 of the cannula 12 advances fromthe sheath to the target site TS.

After the cannula 12 is properly placed, the electrode array 30 isdeployed out of the lumen 18 of the cannula 12, as shown in FIG. 10B.Particularly, the electrode array 30 is fully deployed to span at leasta portion of the treatment region TR, as shown in FIG. 10C.Alternatively, the needle electrodes 26 may be only partially deployedor deployed incrementally in stages during a procedure. The inventivecross-sectional shape of the needle electrodes 26 prevents, or at leastreduces an amount of, bending of the electrodes 26 as the electrodes 26are being deployed.

Next, the RF generator 6 is then connected to the probe assembly 4 viathe electrical connector 38, and the RF generator 6 is operated todeliver ablation energy to the needle electrodes 26 either in amonopolar mode or a bipolar mode. After a desired amount of ablationenergy has been delivered, the treatment region TR is necrosed, therebycreating a lesion on the treatment region TR.

In many cases, a single ablation may be sufficient to create a desiredlesion. However, if it is desired to perform further ablation toincrease the lesion size or to create lesions at different site(s)within the treatment region TR or elsewhere, the needle electrodes 26may be introduced and deployed at different target site(s), and the samesteps discussed previously may be repeated. When a desired lesion attreatment region TR has been created, the needle electrodes 26 areretracted into the lumen 18 of the cannula 12, and the probe assembly 4is removed from the treatment region TR.

It should be noted that although the electrode 26 has been describedwith reference to one type of ablation device, in alternativeembodiments, any of the embodiments of the electrode 26 described hereincan be used with other types of ablation devices, or other ablationdevices having different configurations. For example, in otherembodiments, the electrode 26 can be attached to a heat generatingdevice, which causes the electrode 26 to heat up during use. In suchcases, the electrode 26 is used to deliver ablation energy in a form ofheat.

In some embodiments, the electrode 26 can further include a lumen fordelivering an agent, such as a conductive fluid, during use. FIG. 11illustrates an electrode 200 having fluid delivery capability inaccordance with other embodiments of the invention. The electrode 200includes a distal end 202, a proximal end 204, and a body 206 extendingbetween the distal and the proximal ends 202, 204. The electrode 200also includes a sharp distal tip 210 for penetrating tissue. Theelectrode 200 further includes a lumen 208 located within the body 206,and a distal opening 212 in fluid communication with the lumen 208. Theproximal end 204 of the electrode 200 is configured to be coupled to asource (not shown) of conductive fluid. During use, the electrode 200 isdeployed within target tissue in a similar manner as that describedpreviously, and conductive fluid is delivered to the target tissue fromthe source via the lumen 208. The delivered conductive fluid enhancesthe electrical characteristic of target tissue, thereby allowing thetarget tissue to be ablated more accurately and efficiently. In otherembodiments, instead of using the lumen 208 to deliver conductive fluid,the lumen 208 can be used to deliver other substance, such as coolingfluid to cool the body 206, during use.

FIG. 12 illustrates a cross-sectional view of the electrode 200 of FIG.11. As shown in FIG. 12, at least a portion of the body 206 of theelectrode 200 has an exterior cross-sectional profile that is circular,while the cross-sectional shape of the interior lumen 208 has aplurality of sides 220. The lumen 208 is sized such that a distance 226between a point 222 of intersection of two adjacent sides 220 and acenter 224 of the lumen 208 is equal to a prescribed radius 228 for thelumen. The square cross-sectional shape of the lumen 208 is advantageousover the circular cross-sectional profile (shown as dotted line) in thatthe square cross-sectional profile of the lumen 208 provides bettercross-sectional property (e.g., 1) for the body 206, thereby resultingin the body 206 having a stronger bending stiffness than that of anelectrode with a lumen having a circular cross-sectional profile. Inother embodiments, the distance 226 can be larger than the prescribedradius 228. For example, the lumen 208 can be sized such that the sides220 of the lumen 208 are tangential to a circle having the radius 228.In some embodiments, when the square shape (or other polygon shape) isused for the lumen 208, the radius 240 of the electrode 200 can bereduced while achieving a prescribed bending stiffness.

It should be noted that in alternative embodiments, instead of a squareprofile, the lumen 208 can have other cross-sectional profiles, such asa triangle (FIG. 13), a pentagon (FIG. 14), a hexagon (FIG. 15), and anoctagon (FIG. 16). Also, in other embodiments, instead of the exteriorcircular cross-sectional profile of the body 206 shown, at least aportion of the body 206 along the length of the electrode 200 can haveother exterior cross-sectional profiles, such as those describedpreviously in FIGS. 4-9. In any case, the body 206 and the lumen 208 aresized such the electrode 200 has a prescribed bending stiffness.Further, in other embodiments, instead of having the deployed profileshown in FIG. 3, the electrode 200 can have a straight deployed profile,other deployed curvilinear profiles (such as an arc, or a bent), orother customized deployed profiles.

In further embodiments, instead of using the tissue-penetrating element200 as an electrode, any of the embodiments of the tissue-penetratingelement 200 can be used with other types of medical devices. Forexample, in other embodiments, the tissue-penetrating element 200 can bea component of an agent delivery device (e.g., a needle coupled to asource of agent) or a biopsy device (e.g., a needle coupled to a vacuumsource or to a mechanical component).

In some embodiments, instead of, or in addition to, the electrodeshaving the profiles described previously, the cannula 12 can have any ofthe cross-sectional shapes of FIGS. 11-16. Such configuration improves abending stiffness of the cannula 12, thereby allowing a physician toturn or steer the distal end 14 of the cannula 12 by applying a bendingforce at the proximal end 16. The cannula 12 can have a sharp distal tipfor piercing tissue, or alternatively, a blunt tip. In some embodiments,the cannula 12 can be sized such that the cannula 12 has a prescribedbending stiffness. For example, the cannula 12 can be sized to have aprescribed bending stiffness such that, when the distal end 14 of thecannula 12 is within tissue, the cannula 12 does not substantially flexwhen a physician applies a bending force at the proximal end 16 of thecannula 12. For example, in some embodiments, the cannula 12 can have awall thickness 227 that is between 0.01 cm and 0.1 cm, and morepreferably, between 0.01 cm and 0.03 cm.

It should be noted that although the cannula 12 has been described withreference to an ablation device, in alternative embodiments, the cannula12 can be a component of other types of medical devices. For example, inother embodiments, the cannula 12 can be attached to a container. Insuch cases, the cannula 12 is a medical needle configured to deliver asubstance, such as drug or diagnostic agent, to a patient. In othercases, the cannula 12 can be configured to extract substance from asite.

Although particular embodiments have been shown and described, it shouldbe understood that the above discussion is not intended to limit thepresent invention to these embodiments. It will be obvious to thoseskilled in the art that various changes and modifications may be madewithout departing from the spirit and scope of the present invention.For example, in any of the embodiments described herein, thetissue-penetrating element does not have a sharp tip, and can have ablunt tip instead. Also, in other embodiments, instead of, or inaddition to, the distal opening, the tissue-penetrating element can havea side opening 300 (FIG. 17). Thus, the present invention is intended tocover alternatives, modifications, and equivalents that may fall withinthe spirit and scope of the present invention as defined by the claims.

1. A system for the treatment of solid body tissue, comprising: a tissuepenetrating element having a distal end, a proximal end, a bodyextending between the distal and the proximal ends, the body defining aninterior lumen having a polygon-shaped cross-section; and an agentdelivery device operatively coupled to the proximal end of the tissuepenetrating element, the agent delivery device configured to selectivelydispense a fluid agent into the lumen of the tissue penetrating elementlumen, and a radio frequency generator operatively coupled to the tissuepenetrating element.
 2. The system of claim 1, wherein the tissuepenetrating element comprises a needle.
 3. The system of claim 1,wherein the body of the tissue penetrating element has acircular-cross-section.
 4. The system of claim 1, wherein the body ofthe tissue penetrating element has a polygonal cross-section.
 5. Thesystem of claim 1, wherein the body of the tissue penetrating elementhas a rectangular cross-section.
 6. The system of claim 1, wherein thebody of the tissue penetrating element has a triangular cross-section.7. The system of claim 1, wherein the body of the tissue penetratingelement has a pentagonal cross-section.
 8. The system of claim 1,wherein the body of the tissue penetrating element has a hexagonalcross-section.
 9. The system of claim 1, wherein the body of the tissuepenetrating element has an octagonal cross-section.
 10. The system ofclaim 1, further comprising a vacuum device operatively coupled to theproximal end of the tissue penetrating element, the vacuum sourceproviding a source of vacuum to the lumen of the body.
 11. The system ofclaim 1, the lumen having a triangular-shaped cross-section.